TY - JOUR T1 - COVID-19 containment in the Caribbean: the experience of Small Island Developing States JF - medRxiv DO - 10.1101/2020.05.27.20114538 SP - 2020.05.27.20114538 AU - MM Murphy AU - SM Jeyaseelan AU - C Howitt AU - N Greaves AU - H Harewood AU - KR Quimby AU - N Sobers AU - RC Landis AU - KD Rocke AU - IR Hambleton Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/02/2020.05.27.20114538.abstract N2 - Background Small island developing states (SIDS) have limited absolute resources for responding to national disasters, including health emergencies. Since the first confirmed case of COVID-19 in the Caribbean on 1st March 2020, non-pharmaceutical interventions (NPIs) have been widely used to control the resulting COVID-19 outbreak. We document the variety of government measures introduced across the Caribbean and explore their impact on aspects of outbreak control.Methods Drawing on publically available information, we present confirmed cases and confirmed deaths to describe the extent of the Caribbean outbreak. We document the range of outbreak containment measures implemented by national Governments, focussing on measures to control movement and gatherings. We explore the temporal association of containment measures with the start of the outbreak in each country, and with aggregated information on human movement, using smartphone positioning data. We include a set of comparator countries to provide an international context.Results As of 25th May, the Caribbean reported 18,755 confirmed cases and 631 deaths. There have been broad similarities but also variation in the number, the type, the intensity, and particularly the timing of the NPIs introduced across the Caribbean. On average, Caribbean governments began controlling movement into countries 27 days before their first confirmed case and 23 days before comparator countries. Controls on movement within country were introduced 9 days after the first case and 36 days before comparators. Controls on gatherings were implemented 1 day before the first confirmed case and 30 days before comparators. Confirmed case growth rates and numbers of deaths have remained low across much the Caribbean. Stringent Caribbean curfews and stay-at-home orders coincided with large reductions in community mobility, regularly above 60%, and higher than most international comparator countries.Conclusion Stringent controls to limit movement, and specifically the early timing of those controls has had an important impact on containing the spread of COVID-19 across much of the Caribbean. Very early controls to limit movement into countries may well be particularly effective for small island developing states. With much of the region economically reliant on international tourism, and with steps to open borders now being considered, it is critical that the region draws on a solid evidence-base to balance the competing demands of economics and public health.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNot fundedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The University of the West Indies, Cave Hill campus, Institutional Review Board, Barbados.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis secondary analysis involves the use of four sources of open access data. They are available at the following online locations. The sources are as follows: SOURCE 1. Non-pharmceutical interventions ACAPS COVID-19 Government Measures Database. [Available from: https://www.acaps.org/covid19-government-measures-dataset. SOURCE 2. COVID-19 cases and deaths European Centre for Disease Control (ECDC). Daily data download on the geographic distribution of COVID19 cases worldwide. [Available from: https://www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distribution-covid-19-cases-worldwide. SOURCE 3. COVID-19 cases and deaths Johns Hopkins coronavirus Resource Center. [Available from: https://coronavirus.jhu.edu/map.html. SOURCE 4. Community mobility Google LLC. COVID-19 Community Mobility Reports [Available from: https://www.google.com/covid19/mobility/index.html?hl=en. We supplemented the ACAPS dataset with new information from 6 United Kingdom Overseas Territories. Our full dataset for 31 included countries and 10 non-pharmaceutical interventions (310 data rows) is available at the following temporary location: https://moodle.caribdata.org/lms/enrol/index.php?id=27 https://moodle.caribdata.org/lms/enrol/index.php?id=27 ER -